Page URL: https://www.bionews.org.uk/page_89600

Concern over internet gene tests

18 March 2005
By BioNews
Appeared in BioNews 300

A US company offering genetic tests direct to customers has attracted criticism for not offering patients adequate care, the British Medical Journal (BMJ) reports. But DNA Direct, which offers tests for susceptibility to breast and ovarian cancer via the Internet, says it offers customers exactly the same counselling and testing that they would receive at a cancer centre.

Most cases of breast cancer are not inherited, but around 5-10 per cent are due to a mutation in one of two genes, called BRCA1 and BRCA2. DNA Direct will look for one particular gene mutation for a fee of $586 (£306), the three most common mutations found in women of Ashkenazi Jewish ancestry for $627, or carry out a complete 'gene screen' for $3312.

The tests being offered are those developed by US firm Myriad Genetics, which holds patents relating to the BRCA1 and BRCA2 genes. Previous to the deal with DNA Direct, Myriad had only made its tests available via doctors and cancer clinics. 'As far as we're concerned there's still a qualified physician involved at DNA Direct', said Myriad spokesman Bill Rusconi, adding 'in some parts of the country it's darn hard to get a physician'.

Katherine Rauen, the company's consulting medical director, said that DNA Direct was offering 'standard care' for people with a family history suggestive of hereditary breast cancer. After ordering a test from the company online, a woman receives a phone call from a genetic counsellor, who takes a medical and family history. She then receives a test kit by post, which she takes to a local genetic testing laboratory. The test results are given over the phone, again by a genetic counsellor, and a letter is sent to customers explaining the implications of the test result, including information to give to their family doctor.

Rauen says the tests are aimed at women who do not have access to a cancer centre, or as a first step for those who do not like visiting the doctor. But US medical geneticist Georgia Wiesner told the BMJ that she thinks the service is 'poor patient care'. She argues that the process of getting a breast cancer susceptibility test requires such personalisation that it cannot be done adequately over the phone or internet. Francis Collins, head of the US National Human Genome Research Institute, is also concerned about the service, since it cuts out family doctors. 'As often is the case, science is running ahead of public policy', he commented. DNA Direct is also offering diagnostic tests for Alpha-1 antitrypsin deficiency, thrombophilia and haemochromatosis, and carrier testing for cystic fibrosis.

In April 2003, the UK's Human Genetics Commission recommended that most genetic tests that offer health information should not be sold directly to the public. Its report, entitled 'Genes direct: ensuring the effective oversight of genetic tests supplied directly to the public' called for stricter controls on predictive genetic tests, but not an outright ban.

SOURCES & REFERENCES
At-home genetic tests push boundaries
The Olympian |  13 March 2005
DNA Direct
DNA Direct |  18 March 2005
Do it yourself cancer gene testing raises concerns
British Medical Journal |  19 March 2005
RELATED ARTICLES FROM THE BIONEWS ARCHIVE
8 September 2005 - by BioNews 
The US Preventive Services Task Force has published guidelines on assessing the risk of familial breast and ovarian cancer. It states that genetic counselling is only appropriate for women whose family history suggests they may have inherited a mutation in the BRCA1 and BRCA2 breast cancer genes. The recommendations were...
29 April 2005 - by BioNews 
Testing people to identify those at risk of developing a preventable genetic condition does not make them more anxious, Australian researchers have found. The team investigated the effect of carrying out a genetic test for haemochromatosis, a disorder that causes the body to absorb too much iron. They found that...
18 April 2005 - by BioNews 
African American women at risk of developing breast cancer are much less likely to receive genetic testing, according to a new US study. Researchers at the University of Pennsylvania looked at racial disparities in genetic counselling for an inherited susceptibility to breast and ovarian cancer. Their results, published in the...
14 April 2003 - by BioNews 
Most genetic tests that offer health information should not be sold directly to the public, the UK's human genetics watchdog recommended last week. In a new report entitled 'Genes direct: ensuring the effective oversight of genetic tests supplied directly to the public', the Human Genetics Commission (HGC) called for stricter...
HAVE YOUR SAY
Log in to add a Comment.

By posting a comment you agree to abide by the BioNews terms and conditions


Syndicate this story - click here to enquire about using this story.